IPO Listed

Latigo Biotherapeutics IPO

US$346m raised

Lodged Aug 2026 · NASDAQ: LTGO · US$18.00 cash per share

Advisers

Latigo Biotherapeutics

Issuer

Legal adviser
Issuer
Latigo Biotherapeutics
Issuer based in
United States
Listed
7 Aug 2026
Sector
Biotech
Tags
Biotech, Pharma, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.